Abbott Introduces its RealTime Molecular Test for Human Papillomavirus (HPV … – Wall Street Journal (press release)

Abbott Introduces its RealTime Molecular Test for Human Papillomavirus (HPV
Wall Street Journal (press release)
ABBOTT PARK, IL, May 29, 2013 /CNW Telbec/ – Abbott today announced it has been granted license by the Medical Device Bureau of Health Canada, for its RealTime High Risk HPV molecular diagnostic test for the detection of human papillomavirus (HPV),
Vaccines against cervical cancer and rubella to benefit health of women and girlsHealthCanal.com

all 2 news articles »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *